Hjem › Osteosarkom › New York
Osteosarkom kliniske forsøg i New York
11 studier for Osteosarkom søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- New York Medical College, Valhalla
RekruttererFase 2
Alder 12 til 39 · Alle køn · Opdateret 29. sep. 2026 · NCT04616560Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Montefiore Medical Center, The Bronx
RekruttererFase 1/2
Alder 12 til 40 · Alle køn · Opdateret 3. sep. 2026 · NCT07725380Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- og 11 flere
RekruttererFase 3
Op til 50 år · Alle køn · Opdateret 25. aug. 2026 · NCT05235165Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119SPEARHEAD-3 Pediatric Study
- Memorial Sloan Kettering Kids, New York
RekruttererFase 1/2
Alder 2 til 21 · Alle køn · Opdateret 11. aug. 2026 · NCT05642455Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- University of Rochester, Rochester
- Stony Brook University Medical Center, Stony Brook
- og 1 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 18. maj 2026 · NCT01790152Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
- Memorial Sloan Kettering Westchester (Consent and Followup), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- Memorial Sloan Kettering at Nassau (Consent and Followup), Uniondale
RekruttererObservationsstudie
Alder 4 og opefter · Alle køn · Opdateret 17. apr. 2026 · NCT03442465A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
- Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- og 1 flere
RekruttererFase 2
Alder 6 til 49 · Alle køn · Opdateret 17. mar. 2026 · NCT07477457Upfront Surgical Resection for Osteosarcoma
- Montefiore Medical Center, The Bronx
RekruttererObservationsstudie
Alder 5 til 40 · Alle køn · Opdateret 16. mar. 2026 · NCT06384404Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
- New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
RekruttererFase 2
Alder 1 til 50 · Alle køn · Opdateret 13. mar. 2026 · NCT01804634A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital at Montefiore, The Bronx
RekruttererFase 2
18 Months – 40 Years · Alle køn · Opdateret 12. aug. 2025 · NCT05135975Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.